减肥药或纳入美国医保，特朗普团队成最强“拦路虎”？

格隆汇11-27

当地时间周二，美国白宫在官网宣布，拜登政府推出提案，要求联邦医疗保险（Medicare）和联邦医疗补助（Medicaid）将Wegovy和Ozempic等“减肥神药”纳入承保范围。据媒体报道，这是一项成本高昂但可能广受欢迎的举措，需要特朗普的支持才能成为正式举措。这也是拜登政府最后的重大政策指令之一。受此消息影响，美股减肥药概念股普涨，礼来涨4.55%，Viking Therapeutics涨近...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2486865754?lang=zh_CN&edition=full","thumbnail":"https://img3.gelonghui.com/a4f91-2de5eac7-c0e3-4125-a2d7-96fbc20d5957.jpg?guru_height=759&guru_width=1216","is_english":false,"pubTime":"2024-11-27 09:45","share_image_url":"https://static.laohu8.com/6b8fa6424aebe95f6781d04ef17a1852","id":"2486865754","market":"hk","top_or_hot":-1,"title":"减肥药或纳入美国医保，特朗普团队成最强“拦路虎”？","media":"格隆汇","content":"<div>\n<p>当地时间周二，美国白宫在官网宣布，拜登政府推出提案，要求联邦医疗保险（Medicare）和联邦医疗补助（Medicaid）将Wegovy和Ozempic等“减肥神药”纳入承保范围。据媒体报道，这是一项成本高昂但可能广受欢迎的举措，需要特朗普的支持才能成为正式举措。这也是拜登政府最后的重大政策指令之一。受此消息影响，美股减肥药概念股普涨，礼来涨4.55%，Viking Therapeutics涨近...</p>\n\n<a href=\"https://www.gelonghui.com/p/1388180\">网页链接</a>\n\n</div>\n","source":"gelonghui_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>减肥药或纳入美国医保，特朗普团队成最强“拦路虎”？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n减肥药或纳入美国医保，特朗普团队成最强“拦路虎”？\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-27 09:45 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.gelonghui.com/p/1388180><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>当地时间周二，美国白宫在官网宣布，拜登政府推出提案，要求联邦医疗保险（Medicare）和联邦医疗补助（Medicaid）将Wegovy和Ozempic等“减肥神药”纳入承保范围。据媒体报道，这是一项成本高昂但可能广受欢迎的举措，需要特朗普的支持才能成为正式举措。这也是拜登政府最后的重大政策指令之一。受此消息影响，美股减肥药概念股普涨，礼来涨4.55%，Viking Therapeutics涨近...</p>\n\n<a href=\"https://www.gelonghui.com/p/1388180\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B4R5TH58.HKD","symbol_name":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","start_time":0,"source_url":"https://www.gelonghui.com/p/1388180","article_id":"2486865754","we_media_id":null,"thumbnails":["https://img3.gelonghui.com/a4f91-2de5eac7-c0e3-4125-a2d7-96fbc20d5957.jpg?guru_height=759&guru_width=1216"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486865754","pubTimestamp":1732671925,"columns":[],"sourceInfo":{"source_id":"gelonghui_highlight","name":"格隆汇"},"weMediaInfo":null,"summary":"“减肥双雄”领衔大涨","collect":0,"end_time":0,"defaultTopTitle":"gelonghui.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","HHS":"Harte-Hanks","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","SG9999018865.SGD":"United Global Quality Growth Fd Cl Dist SGD-H","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU0094547139.USD":"abrdn SICAV I - GLOBAL SUSTAINABLE EQUITY FUND \"A\" (USD) ACC","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","BK4585":"ETF&股票定投概念","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU0079474960.USD":"联博美国增长基金A","BK4139":"生物科技","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","SGXZ51526630.SGD":"大华环球创新基金A Acc SGD","SGXZ81514606.USD":"大华环球创新基金A Acc USD","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","VKTX":"Viking Therapeutics, Inc.","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","LLY":"礼来","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","SG9999015978.USD":"利安颠覆性创新基金A","LU0203201768.USD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"AX\" (USD) INC","NVO":"诺和诺德","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","SG9999014898.SGD":"United Global Quality Growth Fund Dis SGD","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","LU0882574139.USD":"富达环球消费行业基金A ACC","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","SG9999001176.USD":"United Global Healthcare Acc USD","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC"},"translate_title":"Diet pills may be included in US medical insurance, Trump team becomes the strongest \"roadblock\"?","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HHS":1,"VKTX":0.9,"LLY":0.9,"NVO":0.9},"content_text":"当地时间周二，美国白宫在官网宣布，拜登政府推出提案，要求联邦医疗保险（Medicare）和联邦医疗补助（Medicaid）将Wegovy和Ozempic等“减肥神药”纳入承保范围。据媒体报道，这是一项成本高昂但可能广受欢迎的举措，需要特朗普的支持才能成为正式举措。这也是拜登政府最后的重大政策指令之一。受此消息影响，美股减肥药概念股普涨，礼来涨4.55%，Viking Therapeutics涨近3%，诺和诺德涨1.5%.美医疗补助覆盖减肥药近年来，肥胖问题在美国愈发严重，已经成为了一个不容忽视的公共健康问题。据悉，美国有42%的人被认为患有肥胖症。疾病控制与预防中心CDC指出，肥胖是一种慢性疾病，会使人们面临患心脏病、糖尿病、呼吸问题、中风和某些癌症的风险。为了应对这一挑战，拜登政府希望通过医疗保险来减轻肥胖患者的经济负担，让更多人能够获得减肥药物的治疗。白宫表示，这些减肥药可以帮助预防2型糖尿病的发展，将心脏病和其他心血管疾病导致的死亡和患病率降低多达20%。但这对于多数美国人来说治疗价格太昂贵了，根本无法负担。一位白宫官员估计，一个月的减肥药供应可能要花费1000元或更多。除了将药物纳入保险，白宫还计划降低药品成本，包括展开药品价格谈判计划和增加市场竞争。联邦医疗保险和医疗补助服务中心主管布鲁克斯-拉舍尔（Chiquita Brooks-LaSure）表示，不希望看到人们不得不等到患有这些额外疾病后才接受治疗。越来越多的医学共识认为，肥胖是一种慢性健康状况。尽管新闻稿中并未提及药物的名称，但仍可知道药物主要指诺和诺德的“司美格鲁肽”以及礼来的“替尔泊肽”。美国卫生与公众服务部长哈维尔·贝塞拉（Xavier Becerra）称，对于患有肥胖症的人来说，今天是好日子。对于那些原本买不起这些药物的美国人来说，这将改变游戏规则。特朗普团队阻拦？就在前不久，被特朗普提名为美国卫生与公众服务部（HHS）部长的Robert F． Kennedy Jr曾强烈反对GLP-1药物，认为它们是解决肥胖危机的错误方法。他的一番言论，直接导致美国医药股直接崩盘了。不过，Kennedy并没有健康领域的学位或正式资格，但他仍将医疗保健以及他所认为的“美国体系的缺陷”作为自己竞选总统的基石，并将慢性病的增加归咎于不健康的食物、不必要的药物（包括某些疫苗）和氟化水。在前不久的一次节目中，肯尼迪指出，如果我们能够每天为每一个人提供三餐健康的食物，我们就能立即解决肥胖和糖尿病的流行问题。他还批评了诺和诺德，称其“指望美国人因为愚蠢和对药物的成瘾而购买这种药物。”尽管他的言论或者只是个人见解，但随着他可能成为卫生与公共服务部部长，这些意见或可能转化为联邦政策。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486865754"}